Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/NC/Burlington
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Burlington, NC

Studies commonly pay $75 to $4,500 per completed study

747 clinical trials are currently recruiting participants within 30 miles of Burlington. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

747studies recruiting
9+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Burlington right now

Top 25 of 747 recruiting studies, sorted by proximity — each links to its official registry page

Nephrotic Syndrome Study Network

Minimal Change Disease (MCD), Membranous Nephropathy N/A Observational 1,200 participants sought
University of North Carolina at Chapel Hill — Chapel Hill, North Carolina (25.7 mi) · Sponsor: University of Michigan
See eligibility & contact on ClinicalTrials.gov (NCT01209000)

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications Phase 3 Interventional 115 participants sought
University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center (Adults and Pediatrics) — Chapel Hill, North Carolina (25.7 mi) · Sponsor: Pierre Fabre Medicament
See eligibility & contact on ClinicalTrials.gov (NCT03394365)

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

Generalized Myasthenia Gravis N/A Observational 500 participants sought
Clinical Trial Site — Chapel Hill, North Carolina (25.7 mi) · Sponsor: Alexion Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04202341)

Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies

Neuromyelitis Optica Spectrum Disorder, NMOSD N/A Observational 200 participants sought
Clinical Trial Site — Chapel Hill, North Carolina (25.7 mi) · Sponsor: Alexion Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05966467)

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Urothelial Cancer, Bladder Cancer Phase 2, Phase 3 Interventional 630 participants sought
Research Site — Chapel Hill, North Carolina (25.7 mi) · Sponsor: Daiichi Sankyo
See eligibility & contact on ClinicalTrials.gov (NCT07129993)

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Colitis, Ulcerative Phase 3 Interventional 882 participants sought
University of North Carolina — Chapel Hill, North Carolina (25.7 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07196748)

A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.

Sepsis, Acute Kidney Injury Phase 2 Interventional 124 participants sought
Research Site — Chapel Hill, North Carolina (25.7 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07215702)

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

Brain Tumor, Recurrent, Brain Tumor N/A Observational 600 participants sought
University of North Carolina Health — Chapel Hill, North Carolina (25.7 mi) · Sponsor: GT Medical Technologies, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04427384)

Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2

Post Operative Surgical Site Infection Phase 3 Interventional 600 participants sought
University of North Carolina at Chapel Hill — Chapel Hill, North Carolina (25.7 mi) · Sponsor: Major Extremity Trauma Research Consortium
See eligibility & contact on ClinicalTrials.gov (NCT04678154)

Evaluation of Endometriosis With 18F-fluorofuranylnorprogesterone PET / MRI

Endometriosis Phase 2 Interventional 24 participants sought
University of North Carolina at Chapel Hill — Chapel Hill, North Carolina (25.7 mi) · Sponsor: University of North Carolina, Chapel Hill
See eligibility & contact on ClinicalTrials.gov (NCT05480995)

Lupus Landmark Study: A Prospective Registry and Biorepository

Systemic Lupus Erythematosus (SLE), Lupus Nephritis N/A Observational 3,500 participants sought
UNC Chapel Hill — Chapel Hill, North Carolina (25.7 mi) · Sponsor: Lupus Research Alliance
See eligibility & contact on ClinicalTrials.gov (NCT05934149)

Hypertonic Saline in NCFB

Bronchiectasis, Non-cystic Fibrosis Bronchiectasis Phase 4 Interventional 20 participants sought
University of North Carolina at Chapel Hill — Chapel Hill, North Carolina (25.7 mi) · Sponsor: University of North Carolina, Chapel Hill
See eligibility & contact on ClinicalTrials.gov (NCT06242795)

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Chronic Migraine Phase 3 Interventional 420 participants sought
Headache Wellness Center /ID# 270568 — Greensboro, North Carolina (18.1 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06810505)

WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis Phase 2 Interventional 164 participants sought
WISPer site in Greensboro, NC — Greensboro, North Carolina (18.1 mi) · Sponsor: Mediar Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06967805)

Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma

Barrett's Esophagus, Esophageal Neoplasm N/A Observational 2,000 participants sought
University of North Carolina at Chapel Hill — Chapel Hill, North Carolina (25.7 mi) · Sponsor: Case Western Reserve University
See eligibility & contact on ClinicalTrials.gov (NCT00288119)

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia (CLL) Phase 2 Interventional 75 participants sought
University of North Carolina /ID# 233313 — Chapel Hill, North Carolina (25.7 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT04895436)

Nutrition for Precision Health, Powered by the All of Us

Nutrition, Health N/A Interventional 8,000 participants sought
University of North Carolina at Chapel Hill - Chapel Hill Clinic — Chapel Hill, North Carolina (25.7 mi) · Sponsor: RTI International
See eligibility & contact on ClinicalTrials.gov (NCT05701657)

Feasibility Test of Action Planning in Pediatric IBD

Inflammatory Bowel Diseases N/A Interventional 60 participants sought
University of North Carolina-Chapel Hill School of Medicine — Chapel Hill, North Carolina (25.7 mi) · Sponsor: University of North Carolina, Chapel Hill
See eligibility & contact on ClinicalTrials.gov (NCT06186752)

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

Colitis, Ulcerative N/A Observational 300 participants sought
University of North Carolina at Chapel Hill, Division of Gastroenterology and Hepatology — Chapel Hill, North Carolina (25.7 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT06398626)

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung Phase 2 Interventional 130 participants sought
University of North Carolina at Chapel Hill — Chapel Hill, North Carolina (25.7 mi) · Sponsor: Johnson & Johnson Enterprise Innovation Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06667908)

A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis Phase 1 Interventional 20 participants sought
Up0122 106 — Chapel Hill, North Carolina (25.7 mi) · Sponsor: UCB Biopharma SRL
See eligibility & contact on ClinicalTrials.gov (NCT06888193)
Actively enrolling

Studies you may be able to join near Burlington

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Burlington

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Cone Health Cancer Center at Alamance Regional

★ 4.7 (35 reviews)
1236 Huffman Mill Rd #120, Burlington, NC 27215
(336) 538-7725
"Outstanding facility and awesome staff!"
— Willie Walker, 5★

Duke Clinical Research Institute

★ 4.9
300 W Morgan St, Durham, NC 27701
(919) 668-8700
"Great awesome place to work!! Loved it❤"
— Ramona Williams, 5★

UNC CTRC (Clinical & Translational Research Center)

★ 5.0
Burnett-Womack Building, 160 Dental Cir, Chapel Hill, NC 27514
(919) 966-1437

North Carolina Clinical Research

★ 5.0
2615 Lake Dr #301, Raleigh, NC 27607
(919) 881-0309
"I donated my brain here. I think..."
— Scott B, 5★

Triad Clinical Trials

★ 5.0
811 Dolley Madison Rd, Greensboro, NC 27410
(336) 235-0991
"Staff is very friendly.They make sure you understand everything with the study"
— Kenyatta Spruill, 5★

Clinical Trials of North Carolina

★ 2.5
811 9th St, Durham, NC 27705
(919) 590-9024
"This is NOT A Clinical trials it is a Dentistry and the phone number on the page do not Work"
— Blue Wallpaper, 1★

University of North Carolina Community Research Center & Clinic

★ 4.5
University of North Carolina Community Research Center & Clinic, 212 Finley Golf Course Rd, Chapel Hill, NC 27517
"Great place for youth, families, couples, and adults to receive evidence-based clinical assessment, therapy, and support from mental health professio…"
— Emma Choplin, 5★

UNC Clinical Research Alliance

123 W Franklin St #530, Chapel Hill, NC 27516
(919) 966-2340

Velocity Clinical Research

★ 4.5
300 E Main St Ste 200, Durham, NC 27701
(919) 503-4711
"Dr Cromwell and the entire staff are professional and caring people who made me feel important and valued during this year long trial.<br>I recommend…"
— Bob Kingsbery, 5★

Clinical trials in Burlington: what's recruiting

The Burlington area currently has 747 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Burlington, the most active research areas are:

  • Cancer & Oncology6 studies
  • Immune & Skin4 studies
  • Liver & Kidney2 studies
  • Lungs & Breathing2 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Burlington, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Burlington

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Burlington participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Burlington pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Burlington safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Burlington, NC?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
How often do new paid studies open in Burlington?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Burlington.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Burlington typically complete one or two studies per year.

Paid clinical trials near Burlington

Other metros within reach

Greensboro, NC597 High Point, NC598 Durham, NC1,696 Cary, NC1,696 Winston-Salem, NC599 Raleigh, NC1,687 Fayetteville, NC124 Roanoke, VA192

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Burlington Heart Failure in Burlington Chronic Kidney Disease (HealthMatch) in Burlington Bladder Issues Due To Spinal Cord Injury in Burlington All conditions

More of NC

Durham1,696 Cary1,696 Raleigh1,687 Charlotte673 Gastonia667 Concord648 Winston-Salem599 High Point598 Greensboro597 Asheville125 Fayetteville124

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts